New study aims to decode cystic fibrosis Flare-Ups

NCT ID NCT07484607

Recruiting now Knowledge-focused Sponsor: Alexander Horsley Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watches 200 people with cystic fibrosis to learn how their bodies react to standard treatments for severe lung infections. Researchers track symptoms, lung function, and collect samples to understand why some people recover better than others. The goal is to use this knowledge to design better ways to prevent future flare-ups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYSTIC FIBROSIS (CF) CYSTIC FIBROSIS PULMONARY EXACERBATION

Contacts and locations

Locations

Cardiff and Vale University Health Board
NOT_YET_RECRUITING

Cardiff, CF14 4XW, United Kingdom
Leeds Adult CF Centre
NOT_YET_RECRUITING

Leeds, LS9 7TF, United Kingdom
Liverpool Heart & Chest Hospital
NOT_YET_RECRUITING

Liverpool, L14 3PE, United Kingdom
Manchester Adult Cystic Fibrosis Centre
RECRUITING

Manchester, M23 9LT, United Kingdom
Newcastle Adult CF Centre
NOT_YET_RECRUITING

Newcastle upon Tyne, NE1 4LP, United Kingdom
Royal Devon and Exeter Hospital (Wonford)
NOT_YET_RECRUITING

Exeter, EX2 5DW, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.